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Cytomegalovirus-associated Immune
Thrombocytopenic Purpura After
Liver Transplantation
Shu-Hao Wei,1 Ming-Chih Ho,2 Yen-Hsuan Ni,1 Dong-Tsamn Lin,1 Po-Huang Lee2*
Immune thrombocytopenic purpura (ITP) is a rare complication after liver transplantation. Infection with
cytomegalovirus (CMV) is a frequent complication of organ transplantation and may induce autoimmune
fdiseases, such as ITP. We report a case of ITP after primary CMV infection in a 3-year-old boy recipient o
tliving-related orthotopic liver transplantation (OLT). The ITP developed 2 years after OLT in this patien
who had received tacrolimus as an immunosuppressive agent, with nadir platelet counts of 5000/mm3 in
2 weeks. The patient was treated with two courses of intravenous gamma globulin (1 g/kg/day for 2 days)
and subsequent oral prednisolone (1.3 mg/kg/day for 2 weeks). He recovered from thrombocytopenia
L4 weeks later. An inadequate immunosuppression, as evident by the low serum tacrolimus level (5.8 ng/m
before the episode of ITP) in this patient, may allow the development of ITP after CMV infection. [J Formos
Med Assoc 2007;106(4):327–329]
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CASE REPORT
Immune thrombocytopenic purpura (ITP) was
previously known as idiopathic thrombocytopenic
purpura. The etiology of so-called “idiopathic”
thrombocytopenic purpura is usually unknown.
However, some viral infections are possible cul-
prits. Viral infection can induce autoimmune dis-
eases including ITP. Probably most acute and/or
chronic ITP may be immunologically caused by
molecular mimicry, and antibodies formed in re-
sponse to viral infection may cross-react with
antigens naturally present on platelets. Infection
with cytomegalovirus (CMV) is a frequent com-
plication of organ transplantation. CMV-related
ITP is rarely reported in transplanted children,
who are usually under immunosuppressive ther-
apy and supposed to be free from such diseases.
 In this report, the possible mechanism in a
3-year-old boy recipient of liver transplantation
after primary CMV infection complicated with
tITP was explored. This case may highlight tha
relatively immunosuppressed patients are still
susceptible to immune-mediated diseases.
Case Report
yThis 3-year-old boy was diagnosed with biliar
atresia 2 months after birth. He underwent Kasai
operation at 67 days of age. However, liver func-
t tion deteriorated progressively in subsequen
rfollow-ups. He underwent living-related live
transplantation at the age of 11 months and the
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donor was his mother. Serum CMV IgM and IgG
antibodies of the donor were both negative while
serum Epstein-Barr virus (EBV) IgM and IgG an-
tibodies of the donor were negative and positive,
respectively. CMV and EBV serologic tests of the
recipient before transplantation were all negative.
He had received blood transfusion during opera-
tion of liver transplantation, and serum CMV IgM
antibody 2 weeks after liver transplantation was
negative. One rejection episode was diagnosed
15 days after transplantation. Steroid pulse ther-
apy was given and his condition was stable. He
received long-term tacrolimus after liver trans-
plantation. He was hospitalized due to suspicion
of post-transplantation lymphoproliferative dis-
order 1.5 years after transplantation and the
dosage of tacrolimus was adjusted later. Serum
CMV IgM antibody turned positive at this admis-
sion. The serial CMV serology data are summa-
rized in the Table. Before the episode of ITP, the
dose of tacrolimus was 0.5 mg/day and the latest
serum level of tacrolimus was 5.8 ng/mL.
He had multiple petechiae and ecchymosis
2 years after transplantation. Intermittent cough
and rhinorrhea were only noted for 1 month be-
fore hospitalization. Thrombocytopenia (platelet
count 5000/μL) was found. Blood smear showed
giant platelets. Serum CMV IgM antibody was
positive while EBV serologic test was negative.
Intravenous immunoglobulin (IVIG) (1 g/kg/
day) was given for 2 days. The platelet count 
was 277,000/μL after the second dose of IVIG.
Unfortunately, petechiae recurred 20 days later
after first ITP. Blood examination showed platelet
count 7000/μL, and CMV and EBV serologic tests
revealed the same results as previously. IVIG
(1 g/kg/day) was given again plus prednisolone
t(1.3 mg/kg/day) for 2 weeks. The platelet coun
elevated to 72,000/μ r L. Regular follow-up fo
6 months showed no more thrombocytopenia.
The clinical course is summarized in the Figure.
Discussion
 In general, childhood acute ITP is considered
to be associated with a viral infection. Some
viruses, such as HIV, CMV, EBV, varicella, herpes
Table. CMV serology data before transplantation, after blood transfusion (post-transplantation Day 15), Day 550,
two hospitalizations for immune thrombocytopenic purpura (ITP) (Days 820 and 845), and Day 900
Days post-OLT Before OLT* 15 550 820 845 900
CMV IgM − − + + + Equivocal
CMV IgG 1:64+ 1:128+ 1:128+ 1:32+
*Before OLT: CMV IgM antibody of both donor and recipient are negative. CMV = cytomegalovirus; OLT = orthotopic liver 
transplantation.
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iF gure. l l f h hC inica  course o  patient. T e patient was ospi-
talized and immune thrombocytopenic purpura (ITP) was
diagnosed on post-transplantation Days 820 and 845,
respectively. Intravenous immunoglobulin (IVIG) 1 g/kg/day
( : one arrow represents one dose of IVIG) for 2 days was
given during both hospitalizations, and oral prednisolone
(* represents prednisolone use) was prescribed when dis-
charged from the second hospitalization. Platelet counts
elevating after each dose of IVIG are shown on Days 820
and 845 of this graph. Serial tacrolimus blood levels are
shown in the upper part of this graph. Two months before
the first ITP, the blood tacrolimus level was 5.8 ng/mL.
simplex, rubella, measles, parvovirus, influenza A,
and hepatitis C, have been identified as causes 
of immune-mediated thrombocytopenia.1 Two-
thirds of children with acute ITP have a history
of an infectious illness a few days to a few weeks
before the onset of thrombocytopenia2 and 13.3%
have documented acute viral infection.3
Molecular mimicry between viral antigens and
host proteins has been implicated in the pathogen-
esis of ITP.4 ITP is an immune-mediated syndrome
with autoantibodies against platelets. Patients with
liver transplantation are under immunosuppres-
sive therapy and have relatively low immunoreac-
tive level. How does ITP, an autoimmune disease,
occur in a patient with liver transplantation under
immunosuppressive therapy?
We found in the literature that some of these
post-transplantation children with acute ITP had
viral infection. One previous report5 showed that
ITP developed in three patients 1 day, 3 months,
and 13 months, respectively, after transplanta-
tion in 266 biliary atresia patients who received
orthotopic liver transplantation (OLT); all were
treated with IVIG with a transient recovery of
thrombocytopenia in two cases and a sustained
recovery in the other. Among the three ITP cases,
one had CMV infection and positive CMV anti-
body, another was not checked, and the other was
negative for CMV. Besides CMV,6 other viruses
including human parvovirus B197 and herpes
zoster virus8 might relate to ITP after transplanta-
tion. These viruses play some roles in stimulation
of immunity that cross-reacts with platelets and
cause ITP in these post-transplantation children.
A recent study9 reported eight cases of new-onset
ITP among 1105 liver transplantation recipients
(incidence of 0.7%) over a 15-year period at 
a single center. There were no positive studies 
of EBV- and CMV-associated ITP in these eight
adult cases.
Patients with liver transplantation under im-
munosuppressive therapy have relatively low im-
munoreactivity. CMV infection is more frequent
in children, with post-transplantation and long-
term use of immunosuppressive agents, than a
normal population. CMV is an immunostimula-
tory agent and has potential to induce autoim-
mune disease. Due to the low serum tacrolimus
level,10 immunity in our patient was not sup-
pressed. CMV infection in this patient triggered
immune response to subsequent immune reac-
tivity to platelet surface antigens, which then in-
duced ITP. Hence, immunosuppressed patients
can still develop an immune-mediated disease,
albeit rarely.
We believe that this case should highlight the
Tpotential for CMV infection in children after OL
gto induce immune-mediated disease, includin
ITP. Further study to elucidate the mechanisms
of viral-mediated immunologic disease in recipi-
ents of transplantation with immunosuppressive
agents is laudatory.
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